Bioethics News

New Approaches Offer Hope for Replacing Beta Cells in Diabetes

June 14, 2016

(Medscape) – Two innovative new approaches to replacing pancreatic beta cells offer hope for treating both type 1 and type 2 diabetes in the future, experts say. On June 10 here at the American Diabetes Association (ADA) 2016 Scientific Sessions, David KC Cooper, MD, PhD, of the Thomas E Starzl Transplantation Institute, Pittsburgh, Pennsylvania, discussed his work on pig islet xenotransplantation using genetically engineered donor pigs, and Chad A Cowan, PhD, of the Harvard Stem Cell Institute, Boston, Massachusetts, spoke about universal donor stem cells created via a technique called “gene editing.”

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.